The Trust Problem: Philippine Universal Health Care and the Politics of Health Fund

Seven years after the Universal Health Care Act became law, Filipino households spent more than PHP 615 billion out of pocket on medical care in a single year. According to the Philippine Statistics Authority, that figure of PHP 615.16 billion, representing 42.7 percent of current health expenditure in 2024, grew by 11.8 percent from the year before even as total health spending continued to rise. [1] The question this raises is not whether universal health care has been enacted. It has. The question is why illness remains so financially burdensome for so many Filipinos despite it.

The usual answer is money. But the Philippines does not lack health financing mechanisms. PhilHealth collected PHP 239.57 billion in premium contributions in 2024. Its reserve fund stood at PHP 280.57 billion. Primary care now absorbs nearly half of total health expenditure. Government has allocated growing resources to health year after year. [2] The more honest question is not whether the money exists, but whether it remains dedicated to the purpose for which it was collected.

The events of the past several years suggest it often does not.

The problem is not that the law failed to anticipate financial pressures. It did. The problem is that the institutions entrusted with protecting health funds proved less insulated from political and fiscal pressures than the law assumed they would be. What emerged was not primarily a funding problem, but a trust problem. The central question facing Philippine universal health care is whether resources collected for health care can remain dedicated to that purpose when competing fiscal priorities arise.

The Framework and What It Was Designed to Do

Republic Act No. 11223 established a coherent financing structure. PhilHealth anchors it, collecting premiums from formal sector workers and their employers while the national government fully subsidizes coverage for those who cannot contribute including the indigent, senior citizens, persons with disability and barangay health workers. The law anticipated that reserves would accumulate. Section 11 provides that those reserves may not exceed two years of projected program expenditures and that any surplus must be returned to members through improved benefits or lower contributions. The same section prohibits, without qualification, the transfer of any portion of the reserve fund to the general fund of the government. [3]

The architecture was sound. The discipline required to protect it proved more difficult to sustain.

PhilHealth's own Annual Report is candid about one failure in particular. When the corporation transitioned to the All Case Rate payment system in 2013, no significant increases or enhancements were made to case rates in the years that followed. Premium contributions grew. The reserve fund deepened. The benefit packages that members could actually claim against remained largely unchanged. [4]

When the reforms finally arrived, they were substantial.

Beginning in 2024, PhilHealth implemented an initial 30 percent increase in most case rates, followed by a 50 percent adjustment across thousands of benefit packages effective January 2025. The breast cancer benefit package rose from PHP 100,000 to PHP 1.4 million. Hemodialysis coverage expanded from 90 to 156 sessions per year. Kidney transplantation benefits increased to as much as PHP 2.146 million. Primary care capitation under Konsulta increased to PHP 1,700 per member together with expanded diagnostic coverage. [5]

These were meaningful improvements. They also arrived only after years of stagnation, sustained public pressure and mounting questions about the fund itself.

That timing is worth holding in mind.

When the Reserve Became a Target

In April 2024, the Department of Finance directed PhilHealth to remit PHP 89.9 billion to the national treasury. The legal basis was Special Provision 1(d) of the General Appropriations Act and DOF Circular No. 003-2024. The transfer was justified as the return of allegedly unutilized government subsidies that had accumulated within the fund. The Cabinet approved the transfer. PhilHealth's board concurred. [6]

The remittance proceeded in tranches. Twenty billion pesos left in May, ten billion in August and thirty billion in October. A final tranche of PHP 29.884 billion was scheduled for release in 2025. Before that could occur, the Supreme Court intervened.

On December 3, 2025, the Court ordered the return of the PHP 60 billion already transferred and permanently prohibited the release of the remaining balance. It further declared both Special Provision 1(d) and DOF Circular No. 003-2024 invalid for violating the protections established under Section 11 of the Universal Health Care Act. [7]

The significance of the decision extends beyond the amount involved.

The controversy exposed a weakness that had always existed but had rarely been tested. Funds accumulated for health care had become vulnerable to competing fiscal priorities. Resources collected from workers, employers and taxpayers for the purpose of financing health services were treated as a potential source of budgetary relief.

One detail deserves particular attention. The Department of Finance's own computation placed the two year reserve requirement at approximately PHP 280.575 billion. PhilHealth's reserve fund at the time stood at approximately PHP 280.574 billion. The difference was less than one million pesos. By the government's own figures, the fund sat almost exactly at the reserve level required by law. The argument that vast excess reserves existed becomes difficult to sustain against those numbers. [8]

The Court's ruling reaffirmed a principle that should have guided the system from the beginning. Health insurance funds are not ordinary government revenues. They are resources held in trust for members and must remain dedicated to the purpose for which they were collected.

In May 2026, health reform advocate Dr. Antonio Leachon filed complaints for plunder and technical malversation before the Office of the Ombudsman, naming Finance Secretary Ralph Recto, Health Secretary Teodoro Herbosa, Acting Finance Secretary Frederick Go, former Budget Secretary Rolando Toledo, PhilHealth CEO Edwin Mercado and former CEO Emmanuel Ledesma Jr. as respondents. The complaints allege harm to hospital payments, dialysis centers and cancer care programs. They remain pending before the Ombudsman and have not been adjudicated. [9]

The Subsidy That Did Not Come

While the reserve transfer drew the most public attention, a quieter decision during the same period may prove equally consequential.

The 2025 General Appropriations Act provided no premium subsidy for indirect contributors despite the Universal Health Care Act's requirement that the national government fully finance their coverage. PhilHealth had requested funding for more than 25 million members in this category including the poor, senior citizens, persons with disabilities and barangay health workers. The request was not funded. [10]

The logic behind these decisions is difficult to reconcile.

Government cited the existence of reserves as reason to withhold the subsidy. It cited those same reserves as the source from which funds could be drawn. The fund was simultaneously too large to justify additional appropriations and available enough to justify extraction.

The practical effect was to shift a legal obligation of government onto PhilHealth's balance sheet. Claims still had to be paid. Coverage still had to be maintained. The burden simply moved elsewhere.

A system designed around predictable public support becomes less stable when reserve funds are expected to substitute for obligations they were never intended to replace.

Entitlement and Assistance

The continued reliance on the Medical Assistance to Indigents and Financially Incapacitated Patients (MAIFIP) program reveals a related institutional tension. [11] MAIFIP provides important support to patients facing catastrophic medical expenses, but it operates differently from PhilHealth. PhilHealth is designed as a rules based entitlement in which benefits arise from membership and eligibility criteria. MAIFIP functions as an assistance mechanism activated through administrative processes.

The persistence of both systems reflects an unresolved question within Philippine health financing. Should access to financial protection depend primarily on universal entitlement or on targeted assistance? Universal health care was intended to move the system toward the former. The continued dependence of many patients on discretionary support mechanisms suggests that the transition remains incomplete.

The Population the Framework Does Not Fully Reach

Less visible than the reserve controversy, but no less structural, is the financing gap that sits between the categories the UHC Act created.

Formal sector workers contribute through payroll. Indirect contributors receive government paid coverage. Between them is a substantial population of informal workers, self employed individuals and unemployed Filipinos whose contribution pathway remains unresolved.

The law grants them membership and benefit eligibility regardless of contribution status. The financing arrangements behind that entitlement are incomplete.

Universal entitlement without a corresponding financing mechanism is not a permanent solution. It is a temporary accommodation that becomes harder to sustain as utilization increases.

Other countries have confronted the same challenge directly. When contributory systems cannot reliably reach certain populations, government finances coverage from general revenue. The Philippines has the legal architecture to do the same under RA 11223. The political decision has largely been to defer it. [12]

The consequences emerge gradually. When claims are filed, the fund absorbs them without a corresponding revenue stream. When government subsidies decline, the gap widens further. The 42.7 percent out of pocket share in 2024 is not solely the result of inadequate benefits. It is also the product of a population that is covered on paper yet incompletely financed in practice.

What the Numbers Now Show

The June 2025 financial statements add an important dimension to the story.

Benefit claims during the first half of 2025 reached approximately PHP 152.6 billion compared with PHP 87.1 billion during the same period in 2024. The increase reflects the impact of expanded benefit packages and higher case rates. [13]

PhilHealth recorded a net loss during the period and reported negative members' equity driven largely by the actuarial value of future insurance obligations. These figures should not be mistaken for insolvency. PhilHealth continues to pay claims as they fall due and retains substantial investment assets.

What they do illustrate is the cumulative effect of delayed adjustments. A decade of largely unchanged case rates was followed by rapid benefit expansion. A PHP 60 billion reserve transfer occurred in the middle of that transition. Government subsidies for indirect contributors disappeared at the same time.

The fund is now absorbing the cost of corrections that could have been implemented gradually, while managing the consequences of decisions that weakened the financial cushion available to support those corrections.

What Protection Would Look Like

The Supreme Court's December 2025 ruling enforced a prohibition that already existed in law. Section 11 of the Universal Health Care Act prohibited the transfer before any circular was issued. The problem was not the absence of legal protection. The problem was the absence of mechanisms that made the protection difficult to circumvent. [14]

Several reforms follow naturally from that observation.

The first is stronger institutional insulation for PhilHealth's reserve fund, premium revenues and investment income. Resources collected for health care should not become available through budgetary reinterpretation or administrative issuances whenever fiscal pressures emerge elsewhere.

The second is a more durable approach to financing populations outside traditional contribution mechanisms. Universal coverage becomes difficult to sustain when entitlement expands faster than the financing arrangements that support it.

The third is a continued shift away from discretionary assistance toward rules based entitlement. Financial protection should depend as little as possible on administrative access and as much as possible on clearly defined rights and eligibility standards.

These reforms do not require a new philosophy of health financing. They require fidelity to the one already embedded in the Universal Health Care Act.

Conclusion

The Philippines built a universal health care framework that works on paper and has begun to work in practice. PhilHealth is collecting premiums, paying claims, expanding benefits and financing primary care at scale. The Universal Health Care Act established institutions and legal protections that, when enforced, do what they were designed to do.

What the past several years exposed is that institutions require more than good design. They require protection from the fiscal and political pressures that form around any large pool of public resources. The attempted reserve transfer, the withdrawal of indirect contributor subsidies, the decade of stagnant case rates and the financing gap affecting the informal sector are not separate failures. They describe what happens when health funds exist without sufficient structural insulation.

The 42.7 percent out of pocket burden carried by Filipino families in 2024 is the measurable result. Reversing it does not necessarily require more money to enter the system. It requires that the money already in the system be treated as what the law says it is: resources held in trust for members, not assets available for competing fiscal purposes.

The Philippines does not face a shortage of health financing institutions. It faces a shortage of institutional protection for the resources those institutions hold. Until that problem is addressed, universal health care will remain vulnerable to the same political pressures that it was designed to shield patients from.

That is the trust problem. And at its core, it is a governance problem that financing alone cannot solve.

Notes

1. Philippine Statistics Authority, Philippine National Health Accounts 2024 (released July 2025). Out-of-pocket expenditure: PHP 615.16 billion; share of current health expenditure: 42.7 percent; year-on-year growth: 11.8 percent.

2. PhilHealth 2024 Annual Report and Statements of Financial Position as at December 31, 2024. Premium contributions: PHP 239,573,300,339; reserve fund: PHP 280,574,913,605.

3. Republic Act No. 11223, Universal Health Care Act, Section 11. Reserve fund ceiling: actuarially estimated two years of projected program expenditures. Surplus must fund improved benefits or reduced contributions. No portion of the reserve fund or its income may accrue to the general fund of the government.

4. PhilHealth 2024 Annual Report, p. 1: 'In 2013, PhilHealth transitioned from a fee-for-service model to a new payment mechanism known as All Case Rates (ACR); no significant increases or enhancements have been made to ACR since then.'

5. PhilHealth 2024 Annual Report, Operational Highlights. Initial 30% case rate increase: PhilHealth Circular PC2024-0001, effective February 2024. 50% adjustment across approximately 9,000 packages: PhilHealth Circular PC2024- 0037, effective January 2025. Breast cancer Z-benefit: from PHP 100,000 to PHP 1.4 million. Hemodialysis: 156 sessions at PHP 6,350 per session. Kidney transplantation: up to PHP 2,146,000. KonSulTa capitation: from PHP 500 (government)/PHP 750 (private) to PHP 1,700 to PHP 2,100.

6. PhilHealth 2024 Annual Report, Notes to Financial Statements, Note 33. DOF letter dated April 24, 2024; Cabinet approval April 3, 2024. Tranche schedule: 1st May 10, 2024, PHP 20 billion; 2nd August 21, 2024, PHP 10 billion; 3rd October 16, 2024, PHP 30 billion; 4th March 31, 2025, PHP 29.884 billion (blocked by TRO). Legal basis: Special Provision 1(d), Chapter XLIII, GAA 2024; DOF Circular No. 003-2024.

7. Supreme Court of the Philippines, December 3, 2025 (ponente: Associate Justice Amy Lazaro-Javier). Court unanimously ordered return of PHP 60 billion and permanently prohibited transfer of remaining PHP 29.884 billion. By majority vote, declared Special Provision 1(d) and DOF Circular No. 003-2024 void for grave abuse of discretion in violation of Section 11 of RA 11223. Five justices dissented from wholesale invalidation. Criminal liability was not adjudicated.

8. PhilHealth 2024 Annual Report, Notes to Financial Statements, Note 33: DOF computation of two-year reserve requirement: PHP 280.575 billion. Actual reserve fund balance at time of transfer: PHP 280.574 billion. Difference: less than PHP 1 million.

9. Complaint for plunder and technical malversation filed by Dr. Antonio Leachon before the Office of the Ombudsman, May 25, 2026. Respondents: Finance Secretary Ralph Recto, Health Secretary Teodoro Herbosa, Acting Finance Secretary Frederick Go, former Budget Secretary Rolando Toledo, PhilHealth CEO Edwin Mercado, former PhilHealth CEO Emmanuel Ledesma Jr. Pending; not adjudicated.

10. PhilHealth 2024 Annual Report, Notes to Financial Statements, Note 33.3: 'GAA FY 2025 was signed into law on December 30, 2024 and no appropriation was made for the subsidy for PhilHealth Indirect Contributors.' RA 11223, Section 10 mandates full national government subsidy for indirect contributors.

11. Department of Health Administrative Order No. 2026-0031 (February 2026). Prohibits guarantee letters from elected officials; designates the Malasakit Program Office as MAIFIP administrator.

12. Commonwealth Fund International Health Care System Profiles, Mexico, 2026. IMSS-Bienestar per capita spending: approximately US$218 (MX$4,225) in 2025. Combined public health programs (IMSS, ISSSTE, IMSSBienestar) cover approximately 87 percent of Mexico's population.

13. PhilHealth Financial Statements as of June 30, 2025 and 2024. Benefit claims H1 2025: PHP 152,599,912,079; H1 2024: PHP 87,117,201,187. Net loss H1 2025: PHP 43,382,926,178. Members' equity June 30, 2025: negative PHP 663,495,733,849, driven by insurance contract liabilities representing the actuarial present value of future benefit obligations.

14. RA 11223, Section 11. The principle that social insurance contributions are members' property held in trust by the government not public funds traces to Supreme Court rulings on the SSS and GSIS from the 1960s onward. The December 2025 PhilHealth ruling is the most recent affirmation of that doctrine.